James Halstead (LON:JHD) Stock Price Passes Below Two Hundred Day Moving Average of $188.72
James Halstead plc (LON:JHD – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 188.72 ($2.53) and traded as low as GBX 169.55 ($2.27). James Halste…
James Halstead (LON:JHD) Stock Price Passes Below Two Hundred Day Moving Average of $188.72
James Halstead plc (LON:JHD – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 188.72 ($2.53) and traded as low as GBX 169.55 ($2.27). James Halstead shares last traded at GBX 173.50 ($2.32), with a volume of 172,759 shares.
James Halstead Trading Up 0.9 %
The company has a quick ratio of 1.13, a current ratio of 3.47 and a debt-to-equity ratio of 4.23. The company has a market cap of £723.13 million, a P/E ratio of 1,577.27, a PEG ratio of 3.19 and a beta of 0.31. The firm’s 50 day moving average is GBX 180.41 and its two-hundred day moving average is GBX 188.72.
James Halstead Company Profile
James Halstead plc manufactures and supplies flooring products for commercial and domestic uses in the United Kingdom, rest of Europe, Scandinavia, Australasia, Asia, and internationally. The company offers its products under the Polyflor, Palettone, Camaro, Polysafe, Recofloor, and Expona names. Its products are used in healthcare, education, and retail infrastructures.
Recommended Stories
- Five stocks we like better than James Halstead
- Find and Profitably Trade Stocks at 52-Week Lows
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Using the MarketBeat Dividend Tax Calculator
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for James Halstead Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for James Halstead and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: ETF Daily News